An Expert Consensus Framework for Asthma Remission as a Treatment Goal.
暂无分享,去创建一个
I. Pavord | W. Busse | T. Casale | S. Szefler | M. Bafadhel | P. Woodruff | C. Ambrose | A. Menzies-Gow | F. Trudo | J. Kocks | A. de Giorgio-Miller | M. Fagerås
[1] L. Nannini. Treat to target approach for asthma , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.
[2] J. Krings,et al. Role of Biologics in Asthma , 2019, American journal of respiratory and critical care medicine.
[3] H. Matsubara,et al. Investigation of novel biomarkers for predicting the clinical course in patients with ulcerative colitis , 2018, Journal of gastroenterology and hepatology.
[4] K. Baker,et al. OP0043 Predictors of drug-free remission in rheumatoid arthritis: results from the prospective biomarkers of remission in rheumatoid arthritis(BIORRA) study , 2018, WEDNESDAY, 13 JUNE 2018.
[5] M. Regueiro,et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults , 2018, The American Journal of Gastroenterology.
[6] T. Nurmagambetov,et al. The Economic Burden of Asthma in the United States, 2008‐2013 , 2018, Annals of the American Thoracic Society.
[7] E. Bel,et al. Clinical predictors of remission and persistence of adult‐onset asthma , 2018, The Journal of allergy and clinical immunology.
[8] S. Ishihara,et al. Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy , 2017, Inflammatory bowel diseases.
[9] T. H. Nguyen,et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.
[10] S. Travis,et al. Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus , 2017, Alimentary pharmacology & therapeutics.
[11] I. Bruce,et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) , 2016, Annals of the rheumatic diseases.
[12] O. Niemelä,et al. A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. , 2016, Respiratory medicine.
[13] Raveendhara R. Bannuru,et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis care & research.
[14] M. Dougados,et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force , 2015, Annals of the rheumatic diseases.
[15] D. Mungan,et al. Prognosis of adult asthma: a 7-year follow-up study. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] Y. Guo,et al. Asthma incidence, remission, relapse and persistence: a population-based study in southern Taiwan , 2014, Respiratory Research.
[17] M. Bugiani,et al. The Course of Asthma in Young Adults: A Population-Based Nine-Year Follow-Up on Asthma Remission and Control , 2014, PloS one.
[18] J. Ahearn,et al. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future , 2013, Therapeutic advances in musculoskeletal disease.
[19] Jinoos Yazdany,et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice , 2012, Arthritis care & research.
[20] L. Boulet,et al. Airway function, inflammation and regulatory T cell function in subjects in asthma remission. , 2012, Canadian respiratory journal.
[21] C. O'Morain,et al. Review article: defining remission in ulcerative colitis , 2011, Alimentary pharmacology & therapeutics.
[22] A. James,et al. Remission of asthma: The next therapeutic frontier? , 2011, Pharmacology & therapeutics.
[23] David T Felson,et al. UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .
[24] E. Matteson,et al. Extended Report , 2022 .
[25] D. Postma,et al. Can AMP induce sputum eosinophils, even in subjects with complete asthma remission? , 2010, Respiratory research.
[26] James Tonascia,et al. Predictors of remitting, periodic, and persistent childhood asthma. , 2010, The Journal of allergy and clinical immunology.
[27] D. Felson,et al. Evidence for predictive validity of remission on long‐term outcome in rheumatoid arthritis: A systematic review , 2010, Arthritis care & research.
[28] A. Lindberg,et al. Outcome and severity of adult onset asthma--report from the obstructive lung disease in northern Sweden studies (OLIN). , 2007, Respiratory medicine.
[29] T. Gislason,et al. Remission of asthma: a prospective longitudinal study from northern Europe (RHINE study) , 2007, European Respiratory Journal.
[30] H. Hoogsteden,et al. Asthma remission: does it exist? , 2003, Current opinion in pulmonary medicine.
[31] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[32] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .